TETmedical, Inc.

TETmedical, Inc. (Tethered Enzyme Technologies) is a clinical stage platform nanomedicine company with a first product being a blood test for stroke.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Fair Haven, NJ, USA
  • Currency USD
  • Founded December 2021
  • Employees 2
  • Incorporation Type C-corp
  • Website tetmedical.com

Company Summary

TET emerged out of groundbreaking innovations originating at Cornell University. Supported by an NIH pioneer award, the technology is de-risked with clinical data and 5 issued, 6 pending patents. Our device is a miniature, functioning, highly stable molecular machine, capable of performing chemical operations thousands of times faster than antibody assays: a patented “TET nanobot”, consisting of thousands of enzymes tethered to a nanoparticle.

Team

  • David Fischell
    CEO

    28 years for three different companies. Raised >$200M, 205 issued us patents, 15 products with FDA approval

Advisors

  • Vice Chair for Research and Chief of Neurocritical Care in the Department of Neurology at Weill Cornell Medicine at New York Presbyterian in NYC.  
    Unconfirmed

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free